ASCEND
BY NTHRYS

NTHRYSPhD AssistanceMolecular Medicine

Molecular Medicine

Field
Category

Molecular Medicine

Select a category to explore research frontiers

Molecular Medicine200 categories·80 research gap frontiers·30 UIRGs·access £41
UIRG Unique Individual Research GapFrontier Research Gap Frontier, groups 3+ UIRGsChip badge 4 UIRGs in that frontier🔓 One fee unlocks every UIRG under a frontier🧬 Illustrated: graphical abstract published
PathFieldCategoryFrontierUIRGPhD assistance services
CRISPR Base Editing and Prime Editing
10 frontiers
30
UIRGS
Development of advanced gene-editing techniques that enable precise nucleotide conversions without creating double-strand breaks in DNA.
RESEARCH GAP FRONTIERS
Chromatin Architecture as a Barrier to Precise Genetic Rewiring3Off-Target Deamination Landscapes in Therapeutic Base Editors3Prime Editor Processivity and RNA Template Engineering3+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Epigenetic Regulation in Cancer Development
10 frontiers
10+
UIRGS
Investigation of histone modifications, DNA methylation, and chromatin remodeling mechanisms driving tumorigenesis and metastasis.
RESEARCH GAP FRONTIERS
Chromatin Remodeling in Early Malignant TransformationDNA Methylation Plasticity and Therapeutic ResistanceHistone Acetylation Dynamics at Oncogenic Enhancers+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Protein Misfolding and Neurodegenerative Diseases
10 frontiers
10+
UIRGS
Study of aggregation-prone proteins in Alzheimer''s, Parkinson''s, and prion diseases to develop therapeutic interventions.
RESEARCH GAP FRONTIERS
Prion-Like Propagation Beyond Amyloid-Beta and TauProteostasis Collapse at the Neuroinflammatory InterfaceLiquid-Liquid Phase Separation in Neurodegenerative Inclusions+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Liquid-Liquid Phase Separation in Cells
10 frontiers
10+
UIRGS
Exploration of biomolecular condensates and their roles in gene regulation, stress responses, and disease pathogenesis.
RESEARCH GAP FRONTIERS
Biomolecular Condensates as Cellular Memory SystemsPhase Separation Dynamics in Transcriptional HubsPathological Condensate Formation in Neurodegeneration+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Immunotherapy and Checkpoint Inhibitors
10 frontiers
10+
UIRGS
Development of monoclonal antibodies and small molecules targeting immune checkpoints to enhance anti-tumor immunity.
RESEARCH GAP FRONTIERS
Checkpoint Paradox: Resistance Mechanisms Beyond PD-1/PD-L1Metabolic Conditioning of T Cell Exhaustion in ImmunotherapySpatial Immunoarchitecture and Response to Checkpoint Blockade+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Single-Cell Transcriptomics and Proteomics
10 frontiers
10+
UIRGS
High-resolution molecular profiling of individual cells to identify cellular heterogeneity and rare cell populations in tissues.
RESEARCH GAP FRONTIERS
Subcellular RNA Localization and Translation DynamicsProtein-RNA Co-localization in Disease StatesTransient Protein Complexes at Single-Cell Resolution+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
RNA Therapeutics and siRNA Delivery
10 frontiers
10+
UIRGS
Engineering of small interfering RNAs and delivery systems for therapeutic gene silencing in human diseases.
RESEARCH GAP FRONTIERS
Lipid Nanoparticle Architecture and Cellular Tropism EngineeringRNA Immunogenicity and Innate Immune Evasion StrategiesOff-Target Effects and Transcriptome-Wide siRNA Specificity+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Organ-on-a-Chip Technology Development
10 frontiers
10+
UIRGS
Microfluidic systems mimicking human organ physiology for drug testing and disease modeling applications.
RESEARCH GAP FRONTIERS
Vascularization Dynamics in Engineered Tissue MicroenvironmentsBarrier Function Reconstitution Across Human-Machine InterfacesMetabolic Gradients and Hypoxia Signaling in Miniaturized Organs+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Metabolic Reprogramming in Cancer
Analysis of altered glucose, lipid, and amino acid metabolism in malignant cells and therapeutic targeting strategies.
Explore frontiers →
CAR-T Cell Engineering and Optimization
Design and enhancement of chimeric antigen receptor-modified T cells for improved cancer immunotherapy efficacy.
Explore frontiers →
Mitochondrial Dysfunction and Disease
Investigation of mitochondrial biogenesis, dynamics, and quality control mechanisms in metabolic and neurodegenerative diseases.
Explore frontiers →
Artificial Intelligence in Drug Discovery
Application of machine learning and deep learning algorithms for molecular target identification and compound screening.
Explore frontiers →
MicroRNA Dysregulation and Disease
Analysis of miRNA biogenesis, target recognition, and aberrant expression in cancer and cardiovascular diseases.
Explore frontiers →
Nanomedicine and Drug Delivery Systems
Development of nanoparticles, liposomes, and polymer carriers for targeted and sustained drug delivery.
Explore frontiers →
Autophagy Regulation and Therapeutic Targeting
Study of cellular autophagy mechanisms and development of agents modulating autophagic flux in disease contexts.
Explore frontiers →
Extracellular Vesicles and Exosomes
Investigation of exosome biogenesis, cargo loading, and therapeutic applications in intercellular communication.
Explore frontiers →
Senescence and Cellular Aging Mechanisms
Characterization of senescent cell phenotypes and development of senolytic therapies targeting aging-related diseases.
Explore frontiers →
Angiogenesis and Vascular Biology
Study of new blood vessel formation and endothelial dysfunction in cancer, ischemia, and cardiovascular diseases.
Explore frontiers →
Fiber Optics and Biosensing Technology
Engineering of optical biosensors for real-time detection of biomarkers and therapeutic drug monitoring.
Explore frontiers →
Microbiome-Host Interactions and Immunity
Analysis of gut microbiota composition and metabolite production affecting immune homeostasis and disease susceptibility.
Explore frontiers →
Splicing Defects and Genetic Diseases
Investigation of pre-mRNA splicing dysregulation and development of splice-modulating therapeutic compounds.
Explore frontiers →
Fibrosis and Tissue Remodeling
Study of myofibroblast activation, extracellular matrix deposition, and antifibrotic therapeutic strategies.
Explore frontiers →
Ubiquitin Proteasome System Dysfunction
Analysis of protein degradation pathways and development of proteasome inhibitors for cancer treatment.
Explore frontiers →
Spatial Transcriptomics and Tissue Mapping
High-resolution mapping of gene expression patterns while preserving tissue architecture and cellular localization.
Explore frontiers →
Blood-Brain Barrier Transport Mechanisms
Investigation of BBB tight junctions and transporter-mediated drug delivery for neurological therapeutic applications.
Explore frontiers →
Synthetic Biology and Genetic Circuits
Design of engineered biological systems and logic circuits for therapeutic sensing and controlled drug release.
Explore frontiers →
Inflammasome Activation and Pyroptosis
Study of inflammatory caspase activation and programmed cell death in infectious and inflammatory diseases.
Explore frontiers →
Neuroinflammation and Microglia Biology
Investigation of microglial activation and neuroinflammatory cascade in neurodegenerative and psychiatric disorders.
Explore frontiers →
Personalized Medicine and Pharmacogenomics
Development of genetic profiling methods for predicting drug response and optimizing patient-specific treatment strategies.
Explore frontiers →
Membrane Protein Topology and Function
Structural and functional characterization of transmembrane proteins as drug targets and signal transducers.
Explore frontiers →
Calcium Signaling and Cellular Homeostasis
Investigation of Ca2+ mobilization, IP3 and ryanodine receptors in regulating cellular processes and disease.
Explore frontiers →
Lysosomes and Lysosomal Storage Diseases
Study of lysosomal biogenesis, autophagy-lysosomal pathway, and enzyme replacement therapies for metabolic disorders.
Explore frontiers →
Histone Deacetylase Inhibitors in Therapy
Development and optimization of HDAC inhibitors targeting epigenetic dysregulation in cancer and neurological diseases.
Explore frontiers →
Pluripotent Stem Cell Differentiation
Directed differentiation protocols for generating patient-specific cell types for disease modeling and cell replacement therapy.
Explore frontiers →
Viral Vector Engineering for Gene Therapy
Optimization of adeno-associated viruses and lentiviruses as safe and efficient gene delivery vehicles.
Explore frontiers →
Tumor Microenvironment and Stromal Cells
Analysis of cancer-associated fibroblasts, immune infiltration, and hypoxia driving tumor progression and treatment resistance.
Explore frontiers →
Protein-Protein Interaction Networks
Systems-level analysis of cellular signaling networks and identification of novel therapeutic intervention points.
Explore frontiers →
Circadian Rhythm Disruption in Disease
Investigation of clock gene mutations and circadian dysfunction in metabolic, neurological, and malignant diseases.
Explore frontiers →
Ferroptosis and Iron Metabolism
Study of ferroptotic cell death mechanisms and iron-dependent processes in cancer and neurodegeneration.
Explore frontiers →
Cryo-Electron Microscopy Structure Determination
High-resolution structural characterization of macromolecular complexes and membrane proteins for drug design.
Explore frontiers →
Immunological Tolerance and Checkpoint Pathways
Molecular mechanisms of immune tolerance, regulatory T cells, and therapeutic modulation of co-signaling molecules.
Explore frontiers →
Tissue Engineering and Biomaterials
Development of scaffold materials and biofactors for regenerative medicine and functional tissue reconstruction.
Explore frontiers →
Extracellular Matrix Mechanics and Biology
Investigation of ECM composition, cross-linking, and mechanotransduction in tissue homeostasis and disease.
Explore frontiers →
Necroptosis and Programmed Necrosis
Analysis of RIPK1-RIPK3-MLKL pathway and therapeutic targeting of regulated necrotic cell death mechanisms.
Explore frontiers →
High-Throughput Screening and Phenotypic Assays
Large-scale compound library screening and cell-based phenotypic assays for lead compound identification.
Explore frontiers →
Metabolomic Profiling and Biomarker Discovery
Global analysis of metabolite profiles for disease diagnosis, prognosis, and therapeutic response prediction.
Explore frontiers →
Cancer Stem Cells and Self-Renewal
Investigation of cancer stem cell markers, asymmetric division, and therapeutic targeting of tumor-initiating cells.
Explore frontiers →
Therapeutic Antibody Engineering and Production
Design of recombinant antibodies with enhanced specificity, affinity, and reduced immunogenicity for clinical applications.
Explore frontiers →
mRNA Translation and Codon Optimization
Study of ribosomal mechanics, translation factors, and codon usage optimization for enhanced protein expression.
Explore frontiers →
Glycosylation and Post-Translational Modifications
Investigation of protein glycosylation patterns, phosphorylation, ubiquitination, and their roles in disease and therapy.
Explore frontiers →
Protein Aggregation and Amyloid Formation
Investigation of molecular mechanisms driving pathological protein aggregation and amyloid-beta accumulation in neurodegenerative disorders.
Explore frontiers →
Immune Checkpoint Ligand Modulation
Development of therapeutic strategies targeting PD-L1, CTLA-4 ligands, and emerging checkpoint molecules in cancer immunotherapy.
Explore frontiers →
DNA Methyltransferase Inhibition Strategies
Characterization of DNMT-targeted therapeutics and their epigenetic effects in reversing aberrant DNA methylation patterns in malignancies.
Explore frontiers →
Neutrophil Extracellular Trap Formation
Study of NET biology and NETosis mechanisms in infection, autoimmunity, and cancer progression using molecular and imaging approaches.
Explore frontiers →
Stromal Fibroblast Activation States
Analysis of cancer-associated fibroblast heterogeneity, activation pathways, and paracrine signaling within tumor ecosystems.
Explore frontiers →
Histone Acetyltransferase Function
Investigation of HAT enzymatic activity, substrate specificity, and therapeutic targeting in chromatin remodeling and gene expression.
Explore frontiers →
Vascular Permeability and Endothelial Dysfunction
Molecular characterization of tight junction disruption, VE-cadherin signaling, and endothelial barrier dysfunction in disease pathogenesis.
Explore frontiers →
Metabolite-Mediated Epigenetic Signaling
Elucidation of how acetyl-CoA, alpha-ketoglutarate, and other metabolites regulate histone and DNA modifications in cellular states.
Explore frontiers →
Cancer Immunoevasion Mechanisms
Study of tumor-intrinsic and microenvironmental strategies including antigen loss, MHC downregulation, and immunosuppressive factor secretion.
Explore frontiers →
Organellar Calcium Dynamics Regulation
Investigation of ER-mitochondrial calcium transfer, IP3 receptor signaling, and organellar calcium stores in cellular signaling.
Explore frontiers →
Therapeutic Monoclonal Antibody Design
Engineering of antibody affinity maturation, Fc-region optimization, and bispecific antibody platforms for disease targeting.
Explore frontiers →
Long Non-Coding RNA Mechanisms
Functional characterization of lncRNA roles in chromatin remodeling, transcriptional regulation, and competing endogenous RNA networks.
Explore frontiers →
Protein Tyrosine Kinase Signaling Networks
Analysis of receptor and non-receptor tyrosine kinase cascades, substrate phosphorylation, and therapeutic kinase inhibition strategies.
Explore frontiers →
Oxidative Stress and Redox Biology
Investigation of reactive oxygen species generation, antioxidant defense mechanisms, and redox-sensitive signaling in pathophysiology.
Explore frontiers →
Membrane Lipid Composition and Signaling
Study of phosphoinositide metabolism, lipid rafts, and membrane lipid-protein interactions in cellular signal transduction.
Explore frontiers →
Protein Ubiquitination and Degron Recognition
Characterization of E3 ligase substrate specificity, ubiquitin code decoding, and targeted protein degradation mechanisms.
Explore frontiers →
Innate Immune Pattern Recognition
Study of TLR, RIG-I, NOD-like, and C-type lectin receptor signaling in pathogen detection and innate immune activation.
Explore frontiers →
Molecular Chaperone Function and Proteostasis
Investigation of Hsp70, Hsp90, and chaperonin-mediated protein folding, trafficking, and quality control in disease contexts.
Explore frontiers →
Conditional Genetic Model Development
Design and characterization of inducible knockouts, conditional knockdowns, and temporal gene manipulation models for molecular pathology.
Explore frontiers →
Extracellular RNA Biomarkers Discovery
Identification and validation of circulating miRNAs, lncRNAs, and cell-free DNA as non-invasive diagnostic and prognostic markers.
Explore frontiers →
G-Protein Coupled Receptor Signaling
Molecular analysis of GPCR activation, heterotrimeric G-protein coupling, beta-arrestin signaling, and therapeutic modulation strategies.
Explore frontiers →
Intestinal Epithelial Barrier Function
Investigation of tight junction organization, intestinal permeability regulation, and epithelial cell-microbiota interactions in health and disease.
Explore frontiers →
Nuclear Export and Import Mechanisms
Study of nucleoporin complexes, importin-exportin pathways, and nuclear-cytoplasmic transport regulation in gene expression control.
Explore frontiers →
Platelet Activation and Aggregation
Molecular characterization of platelet receptor signaling, thrombus formation, and therapeutic antiplatelet target identification.
Explore frontiers →
Tumor Mutational Burden and Neoantigen
Analysis of mutational landscapes, neoantigen prediction, and immunogenicity assessment for personalized cancer vaccine design.
Explore frontiers →
Bacterial Toxin Mechanism and Countermeasures
Investigation of pathogenic bacterial toxin molecular targets and development of neutralizing strategies and antitoxin therapeutics.
Explore frontiers →
RNA Splicing Regulation and Isoforms
Study of spliceosome components, splicing factor mutations, and alternative splicing dysregulation in genetic diseases and cancer.
Explore frontiers →
Endosomal-Lysosomal Trafficking Pathways
Characterization of ESCRT complexes, SNAREs, and Rab GTPases controlling cargo sorting and lysosomal targeting.
Explore frontiers →
Metabolic Enzyme Targeting Therapy
Design of inhibitors targeting metabolic enzymes in glycolysis, lipogenesis, and amino acid metabolism for cancer and metabolic disease treatment.
Explore frontiers →
Retinoic Acid Signaling Pathways
Investigation of RAR and RXR nuclear receptor activation, target gene regulation, and therapeutic applications in differentiation therapy.
Explore frontiers →
Wnt-Beta Catenin Signaling Regulation
Study of Wnt ligand secretion, Frizzled-LRP6 activation, beta-catenin stabilization, and therapeutic pathway inhibition strategies.
Explore frontiers →
Notch Receptor Cleavage and Activation
Molecular characterization of Notch proteolysis, CSL-mediated transcription, and Notch signaling inhibition in developmental and cancer contexts.
Explore frontiers →
Hedgehog Pathway Regulation
Investigation of Sonic Hedgehog processing, Smoothened activation, and Gli transcription factor function in tissue development and malignancy.
Explore frontiers →
TGF-Beta Superfamily Signaling
Analysis of BMP and TGF-beta receptor serine/threonine kinases, Smad activation, and epithelial-mesenchymal transition regulation.
Explore frontiers →
MAPK Cascade Integration and Logic
Study of ERK, p38, and JNK pathway cross-talk, feedback loops, and substrate specificity in cellular decision-making.
Explore frontiers →
PI3K-AKT-mTOR Axis Regulation
Molecular analysis of phosphatidylinositol-3-kinase signaling, AKT kinase substrates, and mTOR complex nutrient sensing in cell growth.
Explore frontiers →
NF-Kappa B Activation and Termination
Investigation of canonical and non-canonical NF-kB pathway activation, negative feedback loops, and inflammatory target gene regulation.
Explore frontiers →
Drug Transporter Expression Modulation
Study of ABC transporter upregulation, multidrug resistance mechanisms, and strategies to overcome transporter-mediated drug efflux.
Explore frontiers →
Cytochrome P450 Metabolism Variability
Characterization of CYP enzyme polymorphisms, gene-drug interactions, and personalized dosing strategies based on metabolic phenotypes.
Explore frontiers →
Angiogenic Factor Signaling Integration
Analysis of VEGF, FGF, and angiopoietin signaling pathways controlling endothelial sprouting, vessel maturation, and vascular stability.
Explore frontiers →
Lymphangiogenesis and Lymphatic Biology
Investigation of VEGF-C and VEGF-D signaling, lymphatic vessel development, and lymphatic dysfunction in inflammation and cancer.
Explore frontiers →
Bone Remodeling and Osteoclastogenesis
Study of RANKL-RANK signaling, osteoclast differentiation from hematopoietic precursors, and therapeutic targeting of bone loss.
Explore frontiers →
Adipogenesis and Browning Mechanisms
Characterization of PPARgamma signaling, brown adipocyte differentiation, and metabolic switching strategies for obesity treatment.
Explore frontiers →
Myogenesis and Muscle Regeneration
Investigation of myogenic regulatory factors, satellite cell activation, and muscle stem cell differentiation pathways in tissue repair.
Explore frontiers →
Hepatic Stellate Cell Activation
Study of HSC transdifferentiation, myofibroblast markers, and TGF-beta driven fibrogenesis in liver disease pathogenesis.
Explore frontiers →
Photodynamic Therapy Mechanisms
Characterization of photosensitizer molecules, singlet oxygen generation, and reactive oxygen species-mediated cell death in cancer treatment.
Explore frontiers →
Radiotherapy Sensitization Strategies
Development of molecular approaches to enhance radiation-induced DNA damage, reduce repair efficiency, and overcome tumor radioresistance.
Explore frontiers →
Oncolytic Virus Engineering
Design of replication-competent viral vectors with enhanced selectivity, immunogenicity, and combination therapy potential for cancer treatment.
Explore frontiers →
Prodrug Bioactivation Chemistry
Investigation of enzyme-mediated prodrug conversion, cancer-selective activation mechanisms, and optimizing therapeutic window in prodrug design.
Explore frontiers →
Aptamer Selection and Optimization
Development of high-affinity, high-specificity DNA and RNA aptamers through SELEX for diagnostics and therapeutic applications.
Explore frontiers →
Metabolic Enzyme Engineering and Catalysis
Design and optimization of engineered enzymes to modulate metabolic pathways for therapeutic intervention in genetic and acquired diseases.
Explore frontiers →
Chromatin Remodeling Complex Function
Study of ATP-dependent chromatin remodeling complexes and their roles in gene regulation and cancer development.
Explore frontiers →
Autophagy Flux and Selective Autophagy
Elucidation of selective autophagy pathways for mitochondrial, protein, and organellar clearance in disease states and aging.
Explore frontiers →
Metabolite-Dependent Signaling Pathways
Characterization of how metabolic intermediates function as signaling molecules regulating gene expression and cellular fate decisions.
Explore frontiers →
Intestinal Barrier Function and Tight Junctions
Analysis of claudin proteins and tight junction architecture in maintaining epithelial integrity and preventing pathogen translocation.
Explore frontiers →
Intracellular Calcium Signaling Networks
Mapping of calcium release channels and IP3 receptor dynamics in controlling cellular responses to extracellular stimuli.
Explore frontiers →
DNA Damage Response and Repair Pathways
Investigation of ATM and ATR signaling cascades and their regulation of homologous recombination and nonhomologous end joining.
Explore frontiers →
Therapeutic Oligonucleotide Chemistry
Development of chemically modified antisense oligonucleotides and locked nucleic acids for modulating disease-associated gene expression.
Explore frontiers →
Protein Structural Dynamics by NMR
Real-time characterization of protein conformational changes and molecular interactions using nuclear magnetic resonance spectroscopy.
Explore frontiers →
Cancer Cell Metabolism and Nutrient Utilization
Study of amino acid, glucose, and lipid metabolism reprogramming that supports malignant transformation and tumor growth.
Explore frontiers →
Organ Transplantation and Immunosuppression
Development of novel immunosuppressive strategies and tolerance-inducing protocols for improving long-term organ allograft survival.
Explore frontiers →
Vascular Endothelial Growth Factor Signaling
Characterization of VEGF receptor tyrosine kinase activation and downstream signaling in pathological neovascularization.
Explore frontiers →
Wnt Signaling and Beta-Catenin Stabilization
Investigation of Wnt ligand-receptor interactions and GSK3-beta inhibition in controlling stem cell maintenance and cancer initiation.
Explore frontiers →
Notch Signaling in Development and Disease
Analysis of Notch receptor cleavage and RBPJ-dependent transcription in cell fate specification and hematopoietic malignancies.
Explore frontiers →
Hedgehog Signaling and Sonic Hedgehog
Elucidation of Smoothened activation and Gli transcription factor regulation in embryonic development and medulloblastoma.
Explore frontiers →
TGF-Beta Signaling and Smad Complexes
Study of type I and type II receptor serine kinase signaling and Smad protein phosphorylation in tissue remodeling.
Explore frontiers →
Nuclear Import and Export Mechanisms
Investigation of nucleoporin complexes and RanGTP gradient-driven nuclear transport of proteins and RNA molecules.
Explore frontiers →
Membrane Trafficking and Vesicular Transport
Characterization of SNARE proteins and Rab GTPases in regulating constitutive and regulated secretory pathways.
Explore frontiers →
Apoptosis Signaling and BCL-2 Family
Determination of mitochondrial outer membrane permeabilization mechanisms and caspase activation in programmed cell death.
Explore frontiers →
Ubiquitin Chain Topology and E3 Ligases
Study of RING and HECT domain E3 ubiquitin ligases and polyubiquitin chain linkage specificity in substrate targeting.
Explore frontiers →
Ion Channel Biophysics and Patho-variants
Investigation of voltage and ligand-gated ion channel mutations causing cardiac arrhythmias and channelopathies.
Explore frontiers →
Nuclear Receptors and Hormone Signaling
Analysis of ligand binding and DNA binding domain interactions controlling steroid and nuclear hormone receptor function.
Explore frontiers →
Kinase Inhibitor Drug Development
Rational design and optimization of small molecule tyrosine and serine-threonine kinase inhibitors for cancer and inflammatory diseases.
Explore frontiers →
Target Engagement and Occupancy Biomarkers
Development of biophysical and molecular assays to assess drug-target interaction kinetics and pharmacological target occupancy.
Explore frontiers →
Inflammatory Cytokine Signaling and JAK-STAT
Investigation of Janus kinase activation and STAT transcription factor phosphorylation in immune cell differentiation and inflammation.
Explore frontiers →
Toll-Like Receptor Innate Immunity
Characterization of pattern recognition receptor signaling through MyD88 and TRIF adaptor proteins in pathogen sensing.
Explore frontiers →
Complement System and C3 Activation
Study of alternative and classical complement pathway activation and membrane attack complex formation in inflammation.
Explore frontiers →
Hemostasis and Coagulation Cascade
Analysis of tissue factor and contact activation pathways driving thrombin generation and fibrin clot formation.
Explore frontiers →
Endothelial Dysfunction and Atherosclerosis
Investigation of endothelial glycocalyx damage and LDL oxidation driving vascular inflammation and plaque formation.
Explore frontiers →
Myocardial Infarction and Cardiac Remodeling
Study of post-ischemic inflammation and matrix metalloproteinase-mediated ventricular remodeling in heart failure progression.
Explore frontiers →
Renal Tubular Function and Ion Transport
Investigation of aquaporin water channels and solute transporters regulating electrolyte homeostasis and urine concentration.
Explore frontiers →
Pulmonary Surfactant Protein Function
Characterization of surfactant protein A and D in modulating surface tension and innate immune responses in airways.
Explore frontiers →
Hepatic Drug Metabolism and Detoxification
Study of cytochrome P450 enzyme expression and phase II conjugation reactions in xenobiotic metabolism and clearance.
Explore frontiers →
Pancreatic Beta-Cell Dysfunction in Diabetes
Investigation of glucose sensing mechanisms and insulin secretion defects in type 2 diabetes pathogenesis.
Explore frontiers →
Thyroid Hormone Metabolism and Signaling
Analysis of iodine incorporation, deiodinase enzymes, and thyroid receptor-mediated gene regulation in metabolic homeostasis.
Explore frontiers →
Adrenal Steroid Synthesis and Regulation
Characterization of CYP11A1 and CYP17 enzymes in glucocorticoid and mineralocorticoid hormone biosynthesis.
Explore frontiers →
Reproductive Hormone Signaling Pathways
Investigation of gonadotropin-releasing hormone and sex hormone receptor function in reproductive axis control.
Explore frontiers →
Bone Remodeling and Osteoclast Biology
Study of RANKL-RANK signaling and osteoclast fusion mechanisms in skeletal homeostasis and osteoporosis.
Explore frontiers →
Cartilage Degradation and Osteoarthritis
Investigation of matrix metalloproteinase and aggrecanase activity in cartilage extracellular matrix destruction.
Explore frontiers →
Skeletal Muscle Fiber Type Specification
Characterization of myogenic regulatory factors and peroxisome proliferator-activated receptor coactivator signaling in muscle differentiation.
Explore frontiers →
Neuromuscular Junction Transmission
Analysis of acetylcholine receptor clustering and neurotransmitter release mechanisms at the motor endplate.
Explore frontiers →
Axonal Transport and Kinesin Motors
Investigation of molecular motor protein function and microtubule-dependent vesicular transport in neuronal axons.
Explore frontiers →
Synaptic Plasticity and Long-Term Potentiation
Study of NMDA receptor-dependent calcium signaling and AMPA receptor trafficking in synaptic strength modification.
Explore frontiers →
Retinal Photoreceptor Degeneration
Investigation of rhodopsin mutations and photoisomerase dysfunction in hereditary retinitis pigmentosa and blindness.
Explore frontiers →
Ototoxicity and Inner Ear Hair Cell Loss
Characterization of aminoglycoside-induced mitochondrial dysfunction in cochlear sensory epithelium leading to hearing loss.
Explore frontiers →
Cutaneous Wound Healing and Re-epithelialization
Analysis of keratinocyte migration and collagen deposition during inflammatory and proliferative phases of dermal repair.
Explore frontiers →
Melanoma Progression and Metastasis
Investigation of BRAF mutation effects and epithelial-mesenchymal transition in cutaneous melanoma tumorigenesis.
Explore frontiers →
Glioblastoma Heterogeneity and Plasticity
Study of glioma stem cell populations and microenvironmental cues driving treatment resistance in brain tumors.
Explore frontiers →
Protein Aggregation and Prion Diseases
Investigation of misfolded protein propagation mechanisms in prion diseases and development of therapeutic interventions targeting aggregate formation and clearance.
Explore frontiers →
Wnt Signaling Pathway Dysregulation
Study of aberrant Wnt/β-catenin signaling in cancer development and regenerative medicine with focus on pathway modulation strategies.
Explore frontiers →
Notch Signaling in Cell Fate Determination
Exploration of Notch receptor mechanisms in controlling stem cell differentiation and tissue homeostasis across developmental contexts.
Explore frontiers →
Hedgehog Signaling and Developmental Biology
Analysis of Sonic Hedgehog pathway regulation in embryonic development and its reactivation in cancer progression and therapy resistance.
Explore frontiers →
NF-kappa B Transcription Factor Networks
Characterization of nuclear factor kappa-B signaling cascades in inflammation, immunity, and cancer-related gene expression programs.
Explore frontiers →
JAK-STAT Pathway in Hematologic Malignancies
Investigation of dysregulated JAK-STAT signaling in myeloproliferative neoplasms and development of targeted kinase inhibitor strategies.
Explore frontiers →
PI3K-AKT-mTOR Axis in Cancer Metabolism
Study of phosphatidylinositol 3-kinase signaling hyperactivation in cancer cells and therapeutic targeting of downstream metabolic rewiring.
Explore frontiers →
MAPK Cascade Mutations in Solid Tumors
Analysis of RAS-RAF-MEK-ERK pathway alterations in melanoma and other cancers with focus on resistance mechanisms to targeted therapy.
Explore frontiers →
Transforming Growth Factor Beta Signaling
Examination of TGF-β/SMAD pathway complexity in epithelial-mesenchymal transition, fibrosis, and tumor progression dynamics.
Explore frontiers →
PTEN Loss and Tumor Suppression Mechanisms
Investigation of phosphatase and tensin homolog deletion consequences in cancer development and immune checkpoint regulation.
Explore frontiers →
TP53 Mutations and Cancer Initiation
Study of tumor protein 53 inactivation mechanisms and restoration of wild-type p53 function in therapeutic applications.
Explore frontiers →
RB Pathway Inactivation in Cell Cycle Control
Analysis of retinoblastoma protein dysfunction in uncontrolled proliferation and development of cell cycle checkpoint reactivation therapies.
Explore frontiers →
Apoptosis Evasion and Anti-Cancer Therapeutics
Exploration of BCL-2 family dysregulation in cancer and design of BH3-mimetic compounds to restore programmed cell death.
Explore frontiers →
Telomere Shortening and Cellular Senescence
Study of telomerase reactivation in cancer and development of telomerase inhibitors combined with immunotherapy strategies.
Explore frontiers →
Tumor Suppressor Gene Methylation Patterns
Analysis of aberrant DNA methylation in promoter regions silencing tumor suppressors and restoration through DNMT inhibitors.
Explore frontiers →
Hypoxia Inducible Factor Pathway Regulation
Characterization of HIF-1α stabilization in tumor hypoxia and angiogenic responses with targeting strategies for normoxic conditions.
Explore frontiers →
Aryl Hydrocarbon Receptor and Immune Tolerance
Investigation of AhR signaling in regulatory T cell differentiation and its modulation for enhanced anti-tumor immunity.
Explore frontiers →
Nuclear Receptor Signaling in Metabolic Disease
Study of peroxisome proliferator-activated receptor function in lipid metabolism and therapeutic intervention in obesity and diabetes.
Explore frontiers →
Estrogen and Androgen Receptor Mutations
Analysis of hormone receptor alterations in breast and prostate cancer driving endocrine therapy resistance and therapeutic escape.
Explore frontiers →
Toll-Like Receptor Signaling in Innate Immunity
Examination of TLR activation mechanisms in pattern recognition and design of agonists for immunotherapy enhancement strategies.
Explore frontiers →
G-Protein Coupled Receptor Pharmacology
Characterization of GPCR signaling bias and allosteric modulation for development of tissue-selective therapeutic agents.
Explore frontiers →
Ion Channel Dysfunction and Cardiac Arrhythmias
Investigation of congenital and acquired ion channelopathies underlying cardiac arrhythmias with therapeutic correction approaches.
Explore frontiers →
Voltage-Gated Potassium Channel Pharmacology
Study of selective potassium channel modulators for treatment of neurological and cardiovascular diseases through channel manipulation.
Explore frontiers →
Aquaporin Water Channel Biology and Disease
Analysis of aquaporin dysfunction in edema, cataracts, and neurological disorders with development of aquaporin-selective modulators.
Explore frontiers →
ABC Transporter-Mediated Drug Resistance
Investigation of ATP-binding cassette transporter overexpression in chemotherapy resistance and strategies for transporter inhibition.
Explore frontiers →
Solute Carrier Transporter Expression Profiling
Characterization of solute carrier family mutations affecting nutrient uptake and implications for precision medicine approaches.
Explore frontiers →
Protease-Activated Receptor Signaling Cascades
Study of PAR activation by coagulation proteases in inflammation, thrombosis, and cancer metastasis progression mechanisms.
Explore frontiers →
Wounding Response and Keratinocyte Migration
Examination of epithelial wound healing mechanisms including growth factor signaling and therapeutic acceleration of skin repair.
Explore frontiers →
Angiogenic Factor Signaling in Vascularization
Investigation of VEGF, angiopoietin, and endothelial growth factor pathways in pathological versus physiological angiogenesis.
Explore frontiers →
Lymphangiogenesis and Metastatic Dissemination
Analysis of lymphatic vessel formation promoting cancer cell transit and lymph node metastasis with therapeutic blocking approaches.
Explore frontiers →
Endothelial Cell Dysfunction and Atherosclerosis
Study of endothelial barrier function loss and inflammation in atherosclerotic plaque formation and cardiovascular disease progression.
Explore frontiers →
Platelet Aggregation and Thrombotic Diseases
Investigation of platelet activation mechanisms in thrombosis and development of antiplatelet therapeutics for stroke prevention.
Explore frontiers →
Coagulation Cascade and Hemostasis Control
Characterization of tissue factor and thrombin signaling in blood clotting with focus on anticoagulant drug development.
Explore frontiers →
Fibrinolysis and Thrombus Resolution Pathways
Analysis of plasminogen activator function in clot degradation and therapeutic modulation for thromboembolic disease management.
Explore frontiers →
Complement System Activation and Regulation
Study of classical and alternative complement pathways in innate immunity and role in inflammatory disease progression.
Explore frontiers →
Neutrophil Extracellular Traps Formation
Investigation of NET release mechanisms in antimicrobial defense and pathological inflammation with therapeutic implications.
Explore frontiers →
Macrophage Polarization and Tumor Immunity
Examination of M1/M2 macrophage differentiation in tumor microenvironment and reprogramming strategies for anti-tumor responses.
Explore frontiers →
Dendritic Cell Maturation and Antigen Presentation
Characterization of dendritic cell activation pathways for enhanced cross-presentation and development of dendritic cell vaccines.
Explore frontiers →
Natural Killer Cell Exhaustion and Function
Analysis of NK cell dysfunction in cancer and chronic infection with strategies to restore cytotoxic capacity through checkpoint modulation.
Explore frontiers →
Regulatory T Cell Differentiation Mechanisms
Study of FOXP3 expression control and Treg suppressive functions in autoimmunity and tumor immune tolerance.
Explore frontiers →
Follicular Helper T Cell Biology in Germinal Centers
Investigation of Tfh cell development and B cell help in antibody responses with implications for vaccine optimization.
Explore frontiers →
B Cell Receptor Signaling and Clonal Selection
Analysis of BCR activation pathways in lymphoma and development of Btk inhibitors for B cell malignancy treatment.
Explore frontiers →
T Cell Receptor Engineering for Adoptive Immunotherapy
Development of TCR-engineered T cells with enhanced specificity and reduced off-target reactivity for solid tumor targeting.
Explore frontiers →
Immune Checkpoint Ligand Shedding Mechanisms
Investigation of PD-L1 and CTLA-4 ligand release by tumor cells enabling immune escape and therapeutic targeting strategies.
Explore frontiers →
Cytokine Storm and Immunopathology in Infection
Study of excessive inflammatory cytokine production in severe viral infections and development of immunomodulatory interventions.
Explore frontiers →
Chemokine Receptor Targeting in Cancer Immunotherapy
Examination of CCR7 and CXCR3 signaling in T cell recruitment and modulation for improved immune cell infiltration.
Explore frontiers →
Interferon Signaling Resistance in Cancer
Analysis of JAK-STAT suppression limiting interferon responses in tumors and combination approaches with checkpoint inhibitors.
Explore frontiers →
Organoid Development and Disease Modeling
Investigation of three-dimensional self-organizing tissue structures derived from stem cells to recapitulate organ-specific pathophysiology and enable personalized disease modeling for drug screening.
Explore frontiers →
Epigenetic Drug Targeting and Chromatin Remodeling
Development of small-molecule inhibitors and chemical probes targeting histone methyltransferases, demethylases, and chromatin remodeling complexes to modulate gene expression in disease states.
Explore frontiers →
Interleukin-6 Trans-Signaling in Inflammation
Characterization of IL-6 classic versus trans-signaling pathways in chronic inflammation and selective IL-6 inhibition strategies.
Explore frontiers →
Tumor Necrosis Factor Receptor Superfamily Signaling
Investigation of TNFR activation in apoptosis and NF-κB signaling with therapeutic applications in cancer and autoimmunity.
Explore frontiers →
Lipid Nanoparticle Formulation and mRNA Delivery
Rational design and optimization of ionizable lipid nanoparticle systems for efficient cellular delivery of therapeutic mRNA and modulation of innate immune responses.
Explore frontiers →